DENTSPLY SIRONA Inc. $XRAY Shares Purchased by Bank of America Corp DE

Key Points

• Bank of America increased its DENTSPLY SIRONA stake by 18.3% in the first quarter, purchasing 375,994 shares to own 2.43 million shares valued at approximately $28.2 million. Institutional investors collectively hold 95.7% of the company.
• Company directors bought a combined 35,160 shares worth $351,179 in the last quarter, signaling insider confidence, although insiders own only 0.46% of outstanding shares.
• DENTSPLY SIRONA exceeded quarterly earnings expectations with EPS of $0.52 versus the $0.35 consensus and revenue of $898 million, but revenue declined 4.1% year over year. Analysts maintain a consensus “Hold” rating with an average price target of $13.38.

Bank of America Corp DE increased its stake in shares of DENTSPLY SIRONA Inc. (NASDAQ:XRAY - Free Report) by 18.3% during the first quarter, according to the company in its most recent disclosure with the SEC. The institutional investor owned 2,432,457 shares of the medical instruments supplier's stock after buying an additional 375,994 shares during the quarter. Bank of America Corp DE owned about 1.21% of DENTSPLY SIRONA worth $28,217,000 at the end of the most recent reporting period.

Other institutional investors and hedge funds also recently added to or reduced their stakes in the company. RBF Capital LLC boosted its holdings in shares of DENTSPLY SIRONA by 2.5% during the first quarter. RBF Capital LLC now owns 205,000 shares of the medical instruments supplier's stock worth $2,378,000 after purchasing an additional 5,000 shares during the last quarter. Arkadios Wealth Advisors acquired a new position in shares of DENTSPLY SIRONA in the 1st quarter valued at about $870,000. California State Teachers Retirement System grew its holdings in shares of DENTSPLY SIRONA by 24.0% during the 1st quarter. California State Teachers Retirement System now owns 232,031 shares of the medical instruments supplier's stock worth $2,692,000 after purchasing an additional 44,918 shares during the period. Royal Bank of Canada grew its holdings in shares of DENTSPLY SIRONA by 137.7% during the 1st quarter. Royal Bank of Canada now owns 256,701 shares of the medical instruments supplier's stock worth $2,978,000 after purchasing an additional 148,702 shares during the period. Finally, Empowered Funds LLC increased its position in DENTSPLY SIRONA by 515.3% during the 1st quarter. Empowered Funds LLC now owns 126,601 shares of the medical instruments supplier's stock worth $1,469,000 after purchasing an additional 106,024 shares in the last quarter. Institutional investors and hedge funds own 95.70% of the company's stock.

Insiders Place Their Bets

In related news, Director Michael J. Barber acquired 15,175 shares of the stock in a transaction dated Thursday, June 11th. The shares were bought at an average cost of $9.88 per share, for a total transaction of $149,929.00. Following the purchase, the director owned 55,943 shares in the company, valued at approximately $552,716.84. This trade represents a 37.22% increase in their position. The acquisition was disclosed in a filing with the Securities & Exchange Commission, which is available through this link. Also, Director Brian P. Mckeon bought 10,000 shares of the business's stock in a transaction that occurred on Friday, June 12th. The shares were bought at an average price of $10.12 per share, with a total value of $101,200.00. Following the transaction, the director directly owned 10,000 shares in the company, valued at $101,200. This trade represents a ∞ increase in their ownership of the stock. Additional details regarding this purchase are available in the official SEC disclosure. Insiders bought a total of 35,160 shares of company stock valued at $351,179 in the last quarter. Insiders own 0.46% of the company's stock.

DENTSPLY SIRONA Stock Performance

NASDAQ XRAY opened at $11.59 on Monday. The firm's 50 day moving average price is $11.94 and its two-hundred day moving average price is $11.85. The company has a debt-to-equity ratio of 1.48, a quick ratio of 1.07 and a current ratio of 1.63. DENTSPLY SIRONA Inc. has a twelve month low of $9.40 and a twelve month high of $14.86. The stock has a market cap of $2.31 billion, a price-to-earnings ratio of -4.21, a PEG ratio of 1.38 and a beta of 0.85.

DENTSPLY SIRONA (NASDAQ:XRAY - Get Free Report) last released its earnings results on Thursday, August 6th. The medical instruments supplier reported $0.52 earnings per share (EPS) for the quarter, beating analysts' consensus estimates of $0.35 by $0.17. The company had revenue of $898.00 million during the quarter, compared to analyst estimates of $889.93 million. DENTSPLY SIRONA had a positive return on equity of 20.84% and a negative net margin of 14.99%.The company's revenue for the quarter was down 4.1% on a year-over-year basis. During the same quarter in the prior year, the company earned $0.52 earnings per share. DENTSPLY SIRONA has set its FY 2026 guidance at 1.400-1.500 EPS. Equities analysts anticipate that DENTSPLY SIRONA Inc. will post 1.49 EPS for the current year.

Analysts Set New Price Targets

A number of equities analysts have commented on the stock. Piper Sandler boosted their price objective on shares of DENTSPLY SIRONA from $13.00 to $14.00 and gave the stock a "neutral" rating in a report on Wednesday, July 29th. BMO Capital Markets restated a "market perform" rating and set a $13.00 target price on shares of DENTSPLY SIRONA in a research note on Friday, August 7th. Barrington Research set a $15.00 target price on DENTSPLY SIRONA in a research report on Monday, August 10th. Weiss Ratings reiterated a "sell (e+)" rating on shares of DENTSPLY SIRONA in a research note on Monday, August 3rd. Finally, Barclays reduced their price target on DENTSPLY SIRONA from $12.00 to $9.00 and set an "underweight" rating for the company in a report on Thursday, June 4th. Three analysts have rated the stock with a Buy rating, nine have assigned a Hold rating and three have given a Sell rating to the company. Based on data from MarketBeat, the stock has a consensus rating of "Hold" and an average price target of $13.38.

About DENTSPLY SIRONA

Dentsply Sirona Inc NASDAQ: XRAY is a leading global manufacturer of professional dental products and technologies. The company, formed through the merger of Dentsply International and Sirona Dental Systems in February 2016, brings together a long heritage of innovation in dental care. Headquartered in Charlotte, North Carolina, Dentsply Sirona develops and markets a comprehensive range of dental consumables, laboratory products, and advanced imaging and CAD/CAM systems.

The company's product portfolio spans preventive, restorative, orthodontic, endodontic and surgical care.

Want to see what other hedge funds are holding XRAY? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for DENTSPLY SIRONA Inc. (NASDAQ:XRAY - Free Report).

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.

Continue following MarketBeat

Add MarketBeat as your preferred source on Google to see our latest stories in your feed.

Add As Preferred Source